CLINICIAN-CONTROLLED SEMI-AUTOMATED MEDICATION MANAGEMENT

• US 20090054754A1
• Filed: 08/08/2008
• Published: 02/26/2009
• Est. Priority Date: 08/21/2007
• Status: Abandoned Application

• Current Assignee: Luminous Medical, Inc.
• Original Assignee: Luminous Medical, Inc.
• Inventors: Thompson, Richard, McMahon, Dave, Hendee, Shonn, Borrello, Mike, Robinson, Mark Ries
• Application Number:
  US12/188,205
• Publication Number:
  US 20090054754A1
• Time in Patent Office: Days
• US Class Current: 600/365
• CPC Class Codes: A61M 2005/14296 Pharmacokinetic models
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G16H 20/17 delivered via infusion or injection

Abstract

The present invention is directed to methods and apparatuses of medication management based upon active authorization of medication infusion by a clinician that can provide for effective management of an analyte in a patient'"'"'s blood, reducing the opportunities for human error common with current manual systems while still placing final control of the medication management with the human clinician. For example, a semi-automated glucose management system can measure the glucose level in a patient'"'"'s blood, recommend infusion parameters to a clinician who can authorize an infusion of glucose or insulin, and infuse the glucose or insulin into the patient.

Claims

1. A semi-automated medication management system, comprising:

an analyte measurement system, adapted to measure the level of an analyte in a patient'"'"'s blood, or an indicator thereof;

an infusion recommendation system, adapted to recommend medication infusion parameters based on information comprising the measured blood analyte level;

an infusion control system, adapted to infuse a medication into the patient, and

an authorization system adapted to allow a clinician to authorize an infusion of the medication into the patent by the infusion control system based on a recommendation to the of infusion parameters by the infusion recommendation system.

2. The medication management system of claim 1, wherein the analyte comprises glucose and the medication comprises glucose or insulin.

3. The medication management system of claim 1, wherein the analyte comprises hematocrit.

4. The medication management system of claim 1, wherein the medication comprises heparin.

5. The medication management system of claim 1, wherein the analyte measurement system, infusion recommendation system, and infusion control system are integrated into a single unit.

6. The medication management system of claim 1, wherein the analyte measurement system is adapted to measure the patient'"'"'s blood analyte level at predetermined time intervals.

7. The medication management system of claim 1, wherein the analyte measurement system is adapted to measure the patient'"'"'s blood analyte level at time intervals determined from patient or treatment parameters.

8. The medication management system of claim 1, wherein the analyte measurement system is adapted to measure the patient'"'"'s blood analyte level at time intervals determined by determining whether a change in a patient condition, a change in an environmental condition, or a combination thereof, indicates a measurement should be made.

9. The medication management system of claim 8, wherein determining whether a change in patient condition, a change in environmental condition, or a combination thereof, comprises applying a physiologic model to the patient'"'"'s condition, the environmental condition, or a combination thereof, and, if the physiological model indicates a blood analyte level that approaches a threshold value, then indicating that a measurement should be made.

10. The medication management system of claim 9, wherein the physiologic model comprises:

a model based on the interactions illustrated in the Netter diagram, an AIDA blood glucose simulator model, a Chase model, a Bergman model, a compartment model with differential equations, an insulin pharmacokinetics and distribution model, a glucose pharmacokinetics and distribution model, a meal model, a glucose/insulin pharmacodynamic model, an insulin secretion and kinetics model, or a combination of two or more of the preceding models.

11. The medication management system of claim 1, wherein the analyte measurement system is adapted to withdraw a volume of blood from a patient, measure the analyte concentration in the blood, and reinfuse at least a portion of the volume of withdrawn blood back into the patient.

12. The medication management system of claim 1, wherein the information of the infusion recommendation system further comprises previous values of the patient'"'"'s blood analyte level, that patient'"'"'s previous response to previous medication infusion, the patient'"'"'s medication treatment characteristics, or a combination thereof.

13. The medication management system of claim 12, wherein the patient'"'"'s medication treatment characteristics comprise a target blood analyte level or a target range, an analyte measurement frequency, the patient'"'"'s age, or the patient'"'"'s medical status, or a combination thereof.

14. The medication management system of claim 1, wherein the infusion recommendation system comprises an imbedded algorithm that can recommend the infusion parameters.

15. The medication management system of claim 1, wherein the infusion recommendation system further comprises an analyte measurement recommendation system to determine a recommended time to measure the analyte level in the patient'"'"'s blood.

16. The medication management system of claim 1, wherein the infusion control system comprises an intravenous infusion pump or subcutaneous infusion means.

17. The medication management system of claim 1, wherein the authorization system comprises means for the clinician to vary the infusion of medication from the recommendation of the infusion recommendation system only if a certain clinician authorization level is provided.

18. The medication management system of claim 1, wherein the authorization system comprises means for the clinician to communicate remotely with the infusion recommendation system or the infusion control system.

19. The medication management system of claim 1, further comprising means for confirming that the medication infusion has been completed.

20. The medication management system of claim 1, further comprising means to perform a medication verification or safety check.

21. The infusion management system of claim 1, further comprising means for automated record keeping for at least one of:

blood analyte level measurements, medication infusion infusion parameters, identity of the authorizing clinician, the timing of blood analyte level measurements, and the timing of infusion parameter adjustments.

24. The medication management system of claim 1, wherein the infusion control system is adapted to infuse one or more of a plurality of medications into a patient, and wherein the infusion recommendation system is adapted to indicate which of the plurality of medications is recommended to infuse.

22. A method for semi-automated medication management, comprising:

measuring an analyte level in a patient'"'"'s blood, or an indicator thereof, with an analyte measurement system;

recommending infusion parameters based on information comprising the measured blood analyte level with an infusion recommendation system;

communicating with a clinician to authorize an infusion of medication into the patent by an infusion control system based on the recommendation of infusion parameters by the infusion recommendation system.

infusing medication into the patient with the infusion control system following the authorizing by the clinician.

23. The method of claim 22, wherein the analyte comprises glucose and the medication comprises glucose or insulin.